1996
DOI: 10.2131/jts.21.supplementiii_691
|View full text |Cite
|
Sign up to set email alerts
|

Immunotoxic Effects of a New Antineoplastic Agent S-1 in Mice : Comparison With S-1, Uft and 5-Fu

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

1999
1999
2008
2008

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 3 publications
0
6
0
Order By: Relevance
“…Several authors have reported this immunosuppression on adult animals [65,66] and humans [67,68] . Other authors have observed that treatment with 5-FU produced a decrease of thymus and spleen weights [69,70] , as well as a reduction of the number of leukocytes in mice [69,71] . This negative effect on immunological cells is due to apoptotic effect of 5-FU, mediated by the activation of the CD95/CD95L system [72,73] and caspase 3 [74] .…”
Section: Discussionmentioning
confidence: 86%
“…Several authors have reported this immunosuppression on adult animals [65,66] and humans [67,68] . Other authors have observed that treatment with 5-FU produced a decrease of thymus and spleen weights [69,70] , as well as a reduction of the number of leukocytes in mice [69,71] . This negative effect on immunological cells is due to apoptotic effect of 5-FU, mediated by the activation of the CD95/CD95L system [72,73] and caspase 3 [74] .…”
Section: Discussionmentioning
confidence: 86%
“…Effects of chitosan on the reduction of immunofunction of spleen induced by 5-FU It has been reported that 5-FU causes immunosuppression and immunotoxicity [15][16][17][18][19] as well as a reduction in the weights of the spleen and thymus. As shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…[5][6][7][8][20][21][22][23] However, there are a number of reports that gastrointestinal toxicity, myelotoxicity and immunotoxicity are induced by the administration of 5-FU through its phosphorylation in the small intestine, bone marrow and spleen. 9,10,[16][17][18][19] Recently, the clinical application of the combination of 5-FU and a modulator, such as leucovorin, methotrexate or cisplatin, has resulted in relatively high response rates in patients with colorectal cancer, lung cancer and breast cancer. [24][25][26][27][28][29][30] However, in these treatments, severe gastrointestinal toxicity with diarrhea and mucositis and hematalogic toxicity with leukopenia appeared to be dose-limiting factors.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For decades, 5-FU has been used for treatment of colon, stomach, pancreas, and breast cancers [3]. But 5-FU has many side-effects as other chemotherapeutic agents, such as myelotoxicity [4], immunotoxicity [5], and gastrointestinal toxicity [6]. Therefore, searching strategies to maintain chemotherapeutic efficacy and decrease the side-effects are important clinical issues.…”
Section: -Fluorouracil (5-fu)mentioning
confidence: 99%